- Home
- TECX vs RLGT Comparison
TECX vs RLGT Comparison
Compare TECX & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- RLGT
- Stock Information
- Founded
- TECX 2019
- RLGT 2001
- Country
- TECX United States
- RLGT United States
- Employees
- TECX N/A
- RLGT N/A
- Industry
- TECX
- RLGT Oil Refining/Marketing
- Sector
- TECX
- RLGT Consumer Discretionary
- Exchange
- TECX Nasdaq
- RLGT Nasdaq
- Market Cap
- TECX 334.4M
- RLGT 287.6M
- IPO Year
- TECX 2018
- RLGT N/A
- Fundamental
- Price
- TECX $21.51
- RLGT $5.94
- Analyst Decision
- TECX Buy
- RLGT
- Analyst Count
- TECX 6
- RLGT 0
- Target Price
- TECX $79.20
- RLGT N/A
- AVG Volume (30 Days)
- TECX 172.8K
- RLGT 177.9K
- Earning Date
- TECX 05-08-2025
- RLGT 05-12-2025
- Dividend Yield
- TECX N/A
- RLGT N/A
- EPS Growth
- TECX N/A
- RLGT 173.51
- EPS
- TECX N/A
- RLGT 0.35
- Revenue
- TECX N/A
- RLGT $888,148,000.00
- Revenue This Year
- TECX N/A
- RLGT $12.86
- Revenue Next Year
- TECX N/A
- RLGT $5.26
- P/E Ratio
- TECX N/A
- RLGT $16.95
- Revenue Growth
- TECX N/A
- RLGT 7.18
- 52 Week Low
- TECX $13.70
- RLGT $5.16
- 52 Week High
- TECX $61.07
- RLGT $7.94
- Technical
- Relative Strength Index (RSI)
- TECX 51.42
- RLGT 43.71
- Support Level
- TECX $21.20
- RLGT $5.90
- Resistance Level
- TECX $22.75
- RLGT $6.08
- Average True Range (ATR)
- TECX 1.43
- RLGT 0.18
- MACD
- TECX 0.01
- RLGT -0.03
- Stochastic Oscillator
- TECX 41.32
- RLGT 3.81
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.